Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Capital Expenditures (2022 - 2023)

Bluejay Diagnostics' Capital Expenditures history spans 2 years, with the latest figure at $87894.0 for Q4 2023.

  • For Q4 2023, Capital Expenditures rose 109.55% year-over-year to $87894.0; the TTM value through Dec 2023 reached $704166.0, up 1610.84%, while the annual FY2024 figure was $306783.0, 56.43% down from the prior year.
  • Capital Expenditures for Q4 2023 was $87894.0 at Bluejay Diagnostics, up from $74498.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $791464.0 in Q3 2022 and bottomed at -$919904.0 in Q4 2022.